Puma Biotechnology, Inc. (PBYI)
NASDAQ: PBYI · Real-Time Price · USD
2.750
-0.030 (-1.08%)
Dec 20, 2024, 4:00 PM EST - Market closed
Puma Biotechnology Employees
Puma Biotechnology had 185 employees as of December 31, 2023. The number of employees decreased by 7 or -3.65% compared to the previous year.
Employees
185
Change (1Y)
-7
Growth (1Y)
-3.65%
Revenue / Employee
$1,316,589
Profits / Employee
$125,627
Market Cap
134.99M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
Nevro | 1,215 |
Metagenomi | 236 |
Pro-Dex | 148 |
Seer, Inc. | 147 |
Vaxart | 109 |
Aligos Therapeutics | 66 |
Achieve Life Sciences | 22 |
Monopar Therapeutics | 10 |
PBYI News
- 5 days ago - Puma Biotechnology: Continuing To Push Their Aurora Kinase Story Forward - Seeking Alpha
- 17 days ago - Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4) - Business Wire
- 4 weeks ago - Puma Biotechnology Announces Initiation of ALISCA™-Breast1 Phase II Trial of Alisertib in Hormone Receptor-Positive, HER2-Negative Metastatic Breast Cancer - Business Wire
- 6 weeks ago - Puma Biotechnology, Inc. (PBYI) Q3 2024 Earnings Conference Call Transcript - Seeking Alpha
- 6 weeks ago - Puma Biotechnology Reports Third Quarter 2024 Financial Results - Business Wire
- 2 months ago - Puma Biotechnology to Host Conference Call to Discuss Third Quarter Financial Results - Business Wire
- 3 months ago - Puma Biotechnology to Present at the H.C. Wainwright 26th Annual Global Investment Conference - Business Wire
- 5 months ago - Puma Biotechnology, Inc. (PBYI) Q2 2024 Earnings Call Transcript - Seeking Alpha